VBI Vaccines

VBI Vaccines, Inc. - Ordinary Shares (NASDAQ: VBIV) will release results on three clinical trials in the first half of 2018, presenting certain investment opportunities of an uncertain nature. Some on the Street predict Buy-worthy data — “free call options.” The Rating BMO...